tiprankstipranks
Trending News
More News >
Natural Health Trends (NHTC)
NASDAQ:NHTC

Natural Health Trends (NHTC) AI Stock Analysis

Compare
257 Followers

Top Page

NHTC

Natural Health Trends

(NASDAQ:NHTC)

Select Model
Select Model
Select Model
Neutral 51 (OpenAI - 5.2)
Rating:51Neutral
Price Target:
$3.50
▲(7.36% Upside)
Action:ReiteratedDate:02/19/26
The score is held down primarily by weakening financial performance (TTM loss and persistent negative operating/free cash flow) and a still-weak price trend versus key moving averages. These are partially offset by a strong balance sheet with low leverage, an unusually high dividend yield, and a sizeable share repurchase that materially reduced share count and dividend burden.
Positive Factors
High Gross Margin
A ~74% gross margin is a durable structural advantage in the health/wellness direct-selling model. High gross margin cushions operating expenses, provides pricing power versus peers, and supports potential profitability recovery if revenue trends stabilize or operating costs are optimized.
Low Financial Leverage
Very low debt gives the company financial flexibility to fund working capital, share repurchases, or restructure without heavy interest burden. Conservative leverage reduces default risk and preserves strategic optionality while management addresses cash-flow and profitability weaknesses.
Major Block Share Repurchase
Retiring a large non-float block is a structural corporate-action that reduces share count, lowers recurring dividend burden, and removes perceived overhang. It improves per-share economics, leaves ~$16M repurchase capacity, and signals active capital-allocation focused on shareholder value.
Negative Factors
Negative Operating Cash Flow
Persistent operating and free cash flow deficits indicate the business is not self-funding. Over months this forces reliance on cash reserves or one-time actions, limits reinvestment in growth or marketing, and increases vulnerability to demand shocks if cash burn continues.
Revenue Decline and TTM Loss
A shrinking top line combined with recent losses signals weakening market traction or execution issues. Sustained revenue declines erode operating leverage, make margin recovery harder, and increase the risk that the company cannot restore profitability without structural changes to sales or cost base.
Eroding Equity & Negative ROE
Material declines in equity and assets plus negative ROE reflect persistent losses that erode shareholder value. Over time this can restrict access to capital, pressure strategic flexibility, and signal that current operations are destroying rather than creating shareholder wealth unless trends reverse.

Natural Health Trends (NHTC) vs. SPDR S&P 500 ETF (SPY)

Natural Health Trends Business Overview & Revenue Model

Company DescriptionNatural Health Trends Corp., a direct-selling and e-commerce company, provides personal care, wellness, and lifestyle products under the NHT Global brand. The company offers wellness products, including liquid, encapsulated, tableted, and powder dietary and nutritional supplements, as well as vitamins and minerals; and herbal products comprising herbal supplements. It also provides beauty products, such as age-defying and hydrating cleansers, creams, lotions, serums, and toners; and lifestyle products, which include weight management and energy enhancing supplements. In addition, the company offers home appliances; daily products, such as oral care, hair care, and body care; and home appliances products. It sells its products directly to consumers, as well as through an e-commerce retail platform in the United States, Canada, Cayman Islands, Mexico, Peru, Hong Kong, Taiwan, China, Singapore, Malaysia, Thailand, Vietnam, South Korea, Japan, India, Russia, Kazakhstan, and Europe. The company was formerly known as Florida Institute of Massage Therapy, Inc. and changed its name to Natural Health Trends Corp. in June 1993. Natural Health Trends Corp. was incorporated in 1988 and is headquartered in Tsim Sha Tsui, Hong Kong.
How the Company Makes MoneyNHTC generates revenue through a multi-tiered direct selling model, where independent distributors sell the company's products directly to consumers. The primary revenue stream comes from product sales, with distributors earning commissions based on their sales performance and the sales of their recruited downlines. NHTC also benefits from membership fees paid by distributors, which grants them access to exclusive products and training resources. Additionally, the company engages in strategic partnerships with various health and wellness organizations, enhancing its market reach and brand visibility. These factors, combined with a robust online sales platform, contribute significantly to NHTC's earnings.

Natural Health Trends Earnings Call Summary

Earnings Call Date:Nov 05, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:May 06, 2026
Earnings Call Sentiment Negative
The call presented notable operational and financial challenges: revenue declined 11% year-over-year, the company returned to a net loss, operating cash burn increased and cash reserves fell roughly 27% year-to-date. Management outlined a clear restructuring plan to achieve $1.5 million in annualized savings, has begun cost reductions (SG&A down ~6.7%), is investing in product launches and technology, and maintains a multi-month liquidity buffer of $32 million. While there are meaningful strategic responses and some positive operational actions, the magnitude of sales decline, profitability deterioration, and increased cash burn outweigh the positives in the near term.
Q3-2025 Updates
Positive Updates
Cost-Savings Restructuring Plan
Company executing a targeted restructuring expected to deliver approximately $1.5 million in annualized savings by mid-2026, including ~10% workforce optimization, lease reductions/exits, and transition of U.S. manufacturing closer to Asia to reduce tariffs and logistics costs; anticipates a one-time charge of ~$250,000 in Q4 2025.
New Product Launches and Member Engagement
Prelaunch of Soo:vea Korean-formulated 4-step moisturizing skin care line in Hong Kong (presale late Sept 2025) and a limited-edition anti-aging cream in Sweden to mark 10 years; hosted member recognition and training events (4-day cruise to Kagoshima, Japan) to strengthen engagement and leadership development.
Maintained High Gross Margin
Gross profit margin remained strong at 73.7% in Q3 2025, only down 0.4 percentage points from 74.1% a year ago despite inventory write-offs related to discontinued components.
Reduction in SG&A Expense
Selling, general and administrative expenses declined by $262,000 (approx. 6.7%) to $3.6 million in Q3 2025 from $3.9 million in Q3 2024, reflecting initial cost control efforts.
Planned Investment in Technology and Marketing
Restructuring will free resources to invest in an AI-enabled marketing app, member interface business suite and new marketing initiatives aimed at driving growth and engagement.
Solid Liquidity Position Despite Decline
Total cash, cash equivalents and marketable securities were $32.0 million at September 30, 2025, providing runway for near-term initiatives and the announced dividend (Board declared $0.20 per share payable Nov 28, 2025).
Negative Updates
Decline in Net Sales
Net sales decreased 11% year-over-year to $9.5 million in Q3 2025 from $10.7 million in Q3 2024; orders declined 5% year-over-year.
Concentration and Weakness in Greater China / Hong Kong
Hong Kong represented 82% of sales and declined 8% year-over-year (or 4% decline excluding timing impact of promotion and presale), with management citing a challenging near-term economic outlook in its largest market.
Operating and Net Losses
Operating loss widened to $495,000 in Q3 2025 from a $275,000 loss in Q3 2024; net loss was $431,000 (−$0.04 per diluted share) versus net income of $35,000 in the prior-year quarter, representing a meaningful deterioration in profitability.
Increased Cash Burn
Net cash used in operating activities for the first 9 months of 2025 was $5.0 million versus $3.5 million in the comparable period a year ago (increase of $1.5 million, ~42.9%); excluding required annual tax installment payments, operating cash provided dropped to $16,000 from $514,000 year-over-year.
Significant Decline in Cash Reserves Year-to-Date
Total cash, cash equivalents and marketable securities decreased to $32.0 million at Sept 30, 2025 from $43.9 million at Dec 31, 2024, a decline of $11.9 million (≈27.1%).
Inventory Write-Offs Impacting Margins
Gross margin was slightly pressured by a write-off of components inventory related to discontinued products, contributing to the margin decline from 74.1% to 73.7%.
Higher Commissions Relative to Sales
Commissions expense as a percent of sales increased to 40.9% in Q3 2025 from 40.5% a year ago, driven by higher weekly commissions earned by members, which puts pressure on operating leverage amid declining sales.
Dividend Reduction Planned
Management anticipates a reduction in the quarterly cash dividend to $0.10 per share in Q1 2026 as part of restructuring to preserve resources, signaling constrained near-term cash priorities (although the Board declared a $0.20 per share dividend on Nov 3, 2025 payable Nov 28).
Company Guidance
Guidance: management expects to realize approximately $1.5 million in annualized cost savings by mid‑2026 through a targeted restructuring (including ~10% workforce reduction, facility lease reductions/exits and shifting U.S. manufacturing closer to Asia); they anticipate a one‑time charge of about $250,000 in Q4 and plan to reduce the quarterly cash dividend to $0.10 per share in Q1 next year (current dividend declared $0.20 per share), actions intended to offset near‑term headwinds (Q3 net sales down 11% to $9.5M, orders down 5%, Greater China/Hong Kong was 82% of sales and declined 8% or 4% excluding a promo/presale), preserve liquidity (cash, cash equivalents and marketable securities $32M at Sept 30 vs $43.9M at Dec 31), and free resources to invest in an AI‑enabled marketing app, a member interface suite and other growth initiatives while improving profitability (Q3 gross margin 73.7% vs 74.1% prior year; commissions 40.9% of sales; SG&A $3.6M; operating loss $495k; net loss $431k or $0.04 per diluted share; YTD operating cash use $5.0M, or $16k excluding a required tax installment).

Natural Health Trends Financial Statement Overview

Summary
Financials are mixed but skew weak: TTM revenue declined (~-2.7%), the company is loss-making in the TTM period, and operating/free cash flow are negative. Offsetting factors include very strong ~74% gross margin stability and low leverage (debt-to-equity ~0.05–0.08), but shrinking assets/equity and negative ROE in TTM pressure the score.
Income Statement
38
Negative
TTM (Trailing-Twelve-Months) revenue is down (about -2.7%) and the company is currently unprofitable (negative EBIT/EBITDA and a net loss). While gross margin remains very strong and stable around ~74% across periods, operating costs are pressuring profitability, with operating margins negative in recent years. Net income was modestly positive in 2022–2024 but has turned negative in the TTM period, highlighting a weakening earnings trajectory.
Balance Sheet
72
Positive
The balance sheet is conservatively levered, with low debt relative to equity (debt-to-equity consistently around ~0.05–0.08), which provides financial flexibility. However, equity and total assets have declined materially over the past several years, and return on equity has weakened and is negative in the TTM period, reflecting deteriorating profitability and potential erosion of shareholder value if losses persist.
Cash Flow
24
Negative
Cash generation is the main weak spot: operating cash flow and free cash flow are negative in the TTM period and have been negative in most recent annual periods (2022–2024). This suggests the business is not currently self-funding through operations despite previously positive cash flow in 2020–2021. The persistence of cash burn increases reliance on the balance sheet over time if conditions do not improve.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue39.78M42.96M43.92M49.13M60.01M
Gross Profit29.25M31.79M32.75M36.47M44.99M
EBITDA-458.00K-1.17M-1.51M-66.00K1.87M
Net Income-882.00K572.00K568.00K313.00K1.08M
Balance Sheet
Total Assets38.43M55.36M69.09M82.82M98.36M
Cash, Cash Equivalents and Short-Term Investments28.87M43.94M56.18M69.67M83.84M
Total Debt3.13M2.64M3.46M4.12M3.17M
Total Liabilities15.00M22.49M27.49M32.67M38.87M
Stockholders Equity23.43M32.87M41.60M50.15M59.49M
Cash Flow
Free Cash Flow-6.07M-3.42M-4.32M-5.00M791.00K
Operating Cash Flow-6.00M-3.37M-4.28M-4.85M1.02M
Investing Cash Flow8.15M-30.07M-46.00K-143.00K-225.00K
Financing Cash Flow-9.21M-9.21M-9.21M-9.14M-9.14M

Natural Health Trends Technical Analysis

Technical Analysis Sentiment
Negative
Last Price3.26
Price Trends
50DMA
3.40
Negative
100DMA
3.44
Negative
200DMA
3.78
Negative
Market Momentum
MACD
-0.05
Positive
RSI
44.23
Neutral
STOCH
18.51
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NHTC, the sentiment is Negative. The current price of 3.26 is below the 20-day moving average (MA) of 3.54, below the 50-day MA of 3.40, and below the 200-day MA of 3.78, indicating a bearish trend. The MACD of -0.05 indicates Positive momentum. The RSI at 44.23 is Neutral, neither overbought nor oversold. The STOCH value of 18.51 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NHTC.

Natural Health Trends Risk Analysis

Natural Health Trends disclosed 39 risk factors in its most recent earnings report. Natural Health Trends reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Natural Health Trends Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
51
Neutral
$28.22M-43.29-0.38%25.20%-5.07%-115.50%
49
Neutral
$19.16M16.10-11.43%-12.53%-3.24%
44
Neutral
$24.26M-1.03-10.64%37.38%
44
Neutral
$1.21M-0.01-8.68%-74.20%64.28%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NHTC
Natural Health Trends
3.28
-0.83
-20.19%
TBHC
Brand House Collective
1.11
-0.27
-19.57%
MOGU
Mogu
2.37
0.04
1.72%
MI
NFT
5.35
2.83
112.30%
OCG
Oriental Culture Holding
0.68
-295.56
-99.77%
JBDI
JBDI Holdings Limited
0.77
0.16
26.72%

Natural Health Trends Corporate Events

Business Operations and StrategyStock Buyback
Natural Health Trends Executes Major Block Share Repurchase
Positive
Feb 17, 2026

On February 17, 2026, Natural Health Trends repurchased all 2,935,227 shares of its common stock beneficially owned by the George K. Broady family trusts in a privately negotiated deal. The block, equal to about 25.5% of outstanding shares, was bought for $2.00 per share, or roughly $5.9 million in total, funded entirely from existing cash and approved by a special board committee.

The transaction, executed under the company’s $70 million share repurchase program, reduces the share count to 8,577,848 and leaves about $16 million available for future buybacks under the plan. Management highlighted that retiring this large, non-float block removes perceived stock overhang, avoids potential market disruption, cuts annual dividend obligations by about $1.2 million at the current rate and is intended to enhance value and liquidity for remaining shareholders while the long-time investor exits for personal financial reasons.

The most recent analyst rating on (NHTC) stock is a Hold with a $4.00 price target. To see the full list of analyst forecasts on Natural Health Trends stock, see the NHTC Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 19, 2026